Los Angeles Capital Management’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-18,494
| Closed | -$291K | – | 1301 |
|
|
2024
Q1 | $291K | Buy |
+18,494
| New | +$291K | ﹤0.01% | 1015 |
|
|
2023
Q3 | – | Sell |
-13,435
| Closed | -$189K | – | 1260 |
|
|
2023
Q2 | $189K | Sell |
13,435
-4,683
| -26% | -$65.9K | ﹤0.01% | 1120 |
|
|
2023
Q1 | $280K | Buy |
+18,118
| New | +$280K | ﹤0.01% | 1028 |
|
|
2022
Q4 | – | Sell |
-10,970
| Closed | -$203K | – | 1300 |
|
|
2022
Q3 | $203K | Hold |
10,970
| – | – | ﹤0.01% | 1168 |
|
|
2022
Q2 | $144K | Buy |
10,970
+390
| +4% | +$5.12K | ﹤0.01% | 1281 |
|
|
2022
Q1 | $98K | Buy |
+10,580
| New | +$98K | ﹤0.01% | 1390 |
|
|
2021
Q2 | – | Sell |
-8,075
| Closed | -$362K | – | 1701 |
|
|
2021
Q1 | $362K | Sell |
8,075
-4,566
| -36% | -$205K | ﹤0.01% | 1365 |
|
|
2020
Q4 | $721K | Buy |
12,641
+380
| +3% | +$21.7K | ﹤0.01% | 1065 |
|
|
2020
Q3 | $629K | Buy |
12,261
+8,110
| +195% | +$416K | ﹤0.01% | 996 |
|
|
2020
Q2 | $248K | Buy |
+4,151
| New | +$248K | ﹤0.01% | 1342 |
|